These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2675405)

  • 1. Treatment of primary liver graft nonfunction with prostaglandin E1.
    Greig PD; Woolf GM; Sinclair SB; Abecassis M; Strasberg SM; Taylor BR; Blendis LM; Superina RA; Glynn MF; Langer B
    Transplantation; 1989 Sep; 48(3):447-53. PubMed ID: 2675405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantation.
    Henley KS; Lucey MR; Normolle DP; Merion RM; McLaren ID; Crider BA; Mackie DS; Shieck VL; Nostrant TT; Brown KA
    Hepatology; 1995 Feb; 21(2):366-72. PubMed ID: 7843707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E1 administration following orthotopic liver transplantation: a randomized prospective multicenter trial.
    Klein AS; Cofer JB; Pruett TL; Thuluvath PJ; McGory R; Uber L; Stevenson WC; Baliga P; Burdick JF
    Gastroenterology; 1996 Sep; 111(3):710-5. PubMed ID: 8780576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of fulminant hepatic failure with intravenous prostaglandin E1.
    Sterling RK; Luketic VA; Sanyal AJ; Shiffman ML
    Liver Transpl Surg; 1998 Sep; 4(5):424-31. PubMed ID: 9724481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of selective prostaglandin E1 treatment on graft perfusion and function after liver transplantation.
    Kornberg A; Schotte U; Kupper B; Hommann M; Scheele J
    Hepatogastroenterology; 2004; 51(56):526-31. PubMed ID: 15086195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report.
    Sinclair SB; Greig PD; Blendis LM; Abecassis M; Roberts EA; Phillips MJ; Cameron R; Levy GA
    J Clin Invest; 1989 Oct; 84(4):1063-9. PubMed ID: 2794044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative prostaglandin e1 infusion in living donor liver transplantation: A double-blind, placebo-controlled randomized trial.
    Bharathan VK; Chandran B; Gopalakrishnan U; Varghese CT; Menon RN; Balakrishnan D; Sudheer OV; Dhar P; Surendran S
    Liver Transpl; 2016 Aug; 22(8):1067-74. PubMed ID: 27152759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating ischaemia-reperfusion injury with prostaglandin E1 reduces the risk of early hepatocellular carcinoma recurrence following liver transplantation.
    Kornberg A; Witt U; Kornberg J; Friess H; Thrum K
    Aliment Pharmacol Ther; 2015 Nov; 42(9):1101-10. PubMed ID: 26282466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E1 for the treatment of primary non-function of the donor organ in liver transplantation.
    Mollison LC; Angus PW; Jones RM
    Med J Aust; 1991 Jul; 155(1):51-3. PubMed ID: 2067441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of intraportal infusion of prostaglandin E1 to improve the hepatic blood flow and graft viability in porcine liver transplantation.
    Kawachi S; Shimazu M; Wakabayashi G; Tanabe M; Shirasugi N; Kumamoto Y; Karahashi T; Yoshida M; Kitajima M
    Transplantation; 1997 Jul; 64(2):205-9. PubMed ID: 9256174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful reversal of primary graft non-function in a liver transplant patient treated with prostaglandin E1.
    Isai H; Sheil AG; McCaughan G; Dolan P; Waugh R
    Aust N Z J Surg; 1992 Apr; 62(4):314-6. PubMed ID: 1550525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma prostaglandin E1 concentrations and hemodynamics during intravenous infusions of prostaglandin E1 in humans and swine.
    Awas JA; Soteriou MC; Drougas JG; Stokes KA; Roberts LJ; Pinson CW
    Transplantation; 1996 Jun; 61(11):1624-9. PubMed ID: 8669108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiated therapy with prostaglandin E1 (alprostadil) after orthotopic liver transplantation: the usefulness of procalcitonin (PCT) and hepatic artery resistive index (RI) for the evaluation of early graft function and clinical course.
    Kornberg A; Grube T; Wagner T; Voigt R; Homman M; Schotte U; Schmidt K; Scheele J
    Clin Chem Lab Med; 2000 Nov; 38(11):1177-80. PubMed ID: 11156354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation.
    Gluckman E; Jolivet I; Scrobohaci ML; Devergie A; Traineau R; Bourdeau-Esperou H; Lehn P; Faure P; Drouet L
    Br J Haematol; 1990 Mar; 74(3):277-81. PubMed ID: 2159315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandins in liver transplantation.
    Merion RM
    Adv Exp Med Biol; 1997; 433():13-8. PubMed ID: 9561096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E1 increases survival with extended anhepatic phase during liver transplantation.
    Xu HS; Rosenlof LK; Pruett TL; Jones RS
    Ann Surg; 1994 Jul; 220(1):53-8. PubMed ID: 8024359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of fulminant viral hepatic failure with prostaglandin E. A preliminary report.
    Sinclair SB; Levy GA
    Dig Dis Sci; 1991 Jun; 36(6):791-800. PubMed ID: 1903342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of long-term graft preservation on intraoperative hemostatic changes in liver transplantation. A comparison between orthotopic and heterotopic transplantation in the pig.
    Bakker CM; Blankensteijn JD; Schlejen P; Porte RJ; Gomes MJ; Lampe HI; Stibbe J; Terpstra OT
    HPB Surg; 1994; 7(4):265-80. PubMed ID: 8204546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of low-dose prostaglandin E1 on intra- and post-operative liver function].
    Hayashida M; Hanaoka K; Shimada Y; Namiki A; Amaha K
    Masui; 1997 May; 46(5):618-27. PubMed ID: 9185458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A trial use of prostaglandin E1 for prevention of hepatic veno-occlusive disease after allogeneic bone marrow transplantation].
    Morio S; Oh H; Kogure K; Ishii H; Ishii A; Nakaseko C; Ikegami T; Kawano E; Matsuura Y; Nishimura M
    Rinsho Ketsueki; 1994 Sep; 35(9):846-52. PubMed ID: 7967053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.